Adam Dinerman, Ph.D. joined as Head of Chemistry, Manufacturing & Controls & Executive Director in January of 2021. Dinerman has over twenty years of experience in pharmaceutical development, technology transfer, and manufacturing to Aro Biotherapeutics. As a CMC Leader at Johnson & Johnson (Janssen R&D), Adam led multiple early and late stage CMC programs across different therapeutic areas for a variety of biotechnology products including monoclonal antibodies (“mAbs”), bi specific mAbs, fusion proteins, and gene therapy products for rare diseases. Prior to holding the CMC Leader position, Adam took on roles of increasing responsibility within the drug product development group at Janssen R&D and also contributed to multiple IND/CTA and BLA submissions during his tenure. Prior to Johnson & Johnson, Adam worked at Genzyme in bioprocess development. Adam received his Ph.D. in Pharmaceutical Sciences from the University of Maryland at Baltimore.
January, 2021 - present
Deputy Director, Data Science And AI at Applied Materials
Director Data Science at Applied Materials
Data Science Solutions Lead at Elevance Health
Director, Digital Learning Labs And Data Science at Applied Materials
VP ML For Drug Discovery, Gred Computational Sciences, Genentech at Genentech
Access the worlds's biggest network of public org charts
Learn more